Patent · US Active

Virus purification

US10537630B2 · kind B2 · utility

13Cited by

5References

12Claims

0Family size

Assignee

Valneva SE · FR

Inventors

Jana Barbero Calzado · Wien, AT
Mario Nebenführ · Wien, AT
Robert Schlegl · Siegenfeld, AT
Michael Weber · Wien, AT
Jürgen Heindl-Wruss · Wien, AT

Key dates

Filing date	Dec 23, 2016
Grant date	Jan 21, 2020
Priority date	—
Expiry date	Dec 23, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are improved purification methods for virus vaccines and compositions. Also described are Zika, Chikungunya, dengue and yellow fever vaccines and methods of producing and administering said vaccines to subjects in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.